User profiles for "author:Mathurin Fumery"
 | Fumery MathurinCHU Amiens Verified email at chu-amiens.fr Cited by 9492 |
Natural history of adult ulcerative colitis in population-based cohorts: a systematic review
Background & Aims A comprehensive knowledge of the natural history of ulcerative colitis
(UC) helps understand disease evolution, identify poor prognostic markers and impact of …
(UC) helps understand disease evolution, identify poor prognostic markers and impact of …
Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis
Background Data are needed to inform the positioning of biologic therapy in the treatment of
moderate-to-severe Crohn's disease, both first line and after previous biologic exposure. We …
moderate-to-severe Crohn's disease, both first line and after previous biologic exposure. We …
First-and second-line pharmacotherapies for patients with moderate to severely active ulcerative colitis: an updated network meta-analysis
Background & Aims We compared the efficacy and safety of different first-line (biologic-
naïve) and second-line (prior exposure to tumor necrosis factor [TNF] antagonists) agents for …
naïve) and second-line (prior exposure to tumor necrosis factor [TNF] antagonists) agents for …
Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study
Data on the natural history of elderly-onset inflammatory bowel disease (IBD) are scarce.
Methods In a French population-based cohort we identified 841 IBD patients> 60 years of …
Methods In a French population-based cohort we identified 841 IBD patients> 60 years of …
Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD)
C Gower-Rousseau, F Vasseur, M Fumery… - Digestive and Liver …, 2013 - Elsevier
Most data regarding the natural history of inflammatory bowel diseases and their therapeutic
management are from tertiary referral-centres. However, the patients followed in these …
management are from tertiary referral-centres. However, the patients followed in these …
Systematic review with network meta‐analysis: first‐and second‐line pharmacotherapy for moderate‐severe ulcerative colitis
Background There are limited data to inform positioning of agents for treating moderate‐
severe ulcerative colitis (UC). Aim To assess comparative efficacy and safety of different …
severe ulcerative colitis (UC). Aim To assess comparative efficacy and safety of different …
Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies
M Fumery, C Xiaocang, L Dauchet… - Journal of Crohn's …, 2014 - academic.oup.com
Objective Patients with inflammatory bowel disease (IBD) are at increased risk of having
venous thromboembolism. The magnitude of this risk has yet to be determined. The question …
venous thromboembolism. The magnitude of this risk has yet to be determined. The question …
Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study
Objective The Epi-IBD cohort is a prospective population-based inception cohort of
unselected patients with inflammatory bowel disease from 29 European centres covering a …
unselected patients with inflammatory bowel disease from 29 European centres covering a …
Deep remission at 1 year prevents progression of early Crohn's disease
Background & Aims We investigated the effects of inducing deep remission in patients with
early Crohn's disease (CD). Methods We collected follow-up data from 122 patients (mean …
early Crohn's disease (CD). Methods We collected follow-up data from 122 patients (mean …
Systematic review and network meta‐analysis: first‐and second‐line biologic therapies for moderate‐severe Crohn's disease
Background There are limited data to inform positioning of agents for treating moderate‐
severe Crohn's disease (CD). Aim We assessed comparative efficacy and safety of first‐line …
severe Crohn's disease (CD). Aim We assessed comparative efficacy and safety of first‐line …